Dysregulation of DIXDC1 is closely associated with the development and progression of a variety of cancers and can activate the PI3K/AKT signalling pathway as well as the Wnt signalling pathway, which regulates β-catenin entry into the nucleus [72]. The gene discussed is AKT1; the disease is cancer.